News

Vaccine Developers Promise Diversity in Clinical Trials

Vaccine Developers Promise Diversity in Clinical Trials

Coronavirus vaccine developers have pledged their commitment to diversity in clinical trials. "Ensuring diversity in these trials, including in terms of race, ethnicity, gender, age, and other factors, is a priority in our efforts," said Menelas Pangalos, AstraZeneca Plc's executive vice president of biopharmaceutical research & development. With an extensive global network and a direct-to-patient service offering, Yourway can bring trial supplies around the world in hours, not days.

Back to Index
Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Media

Articles

The New Normal in Clinical Trial Protection

Open chat
Come chat with us!
Hello! How can I help you?